Trillium

ChenMed Receives Advanced Provider Partner Awards from Wellcare

Retrieved on: 
Thursday, April 28, 2022

ATLANTA, MEMPHIS, Tenn., NEW ORLEANS, and ORLANDO, Fla., April 28, 2022 /PRNewswire/ -- ChenMed announced today it is the recipient of seven Advanced Provider Partner Awards from Wellcare, a leading Medicare Advantage plan. The awards recognize ChenMed centers for providing excellent quality and service to Wellcare Medicare Advantage members based on the Centers for Medicare & Medicaid Services' (CMS) Plan Year 2022 Star Ratings.

Key Points: 
  • Awards Recognize Excellence in Clinical Quality, Member Experience, Membership Growth and Commitment to Value-Based Care
    ATLANTA, MEMPHIS, Tenn., NEW ORLEANS, and ORLANDO, Fla., April 28, 2022 /PRNewswire/ -- ChenMed announced today it is the recipient of seven Advanced Provider Partner Awards from Wellcare, a leading Medicare Advantage plan.
  • The awards recognize ChenMed centers for providing excellent quality and service to Wellcare Medicare Advantage members based on the Centers for Medicare & Medicaid Services' (CMS) Plan Year 2022 Star Ratings.
  • "We are honored to be recognized as an Advanced Provider Partner by Wellcare," said Dr. Christopher Chen, ChenMed CEO.
  • Advanced Provider Partners (APPs) are multi-state Medicare physician groups who are committed to providing high-quality care while operating under value-based care models.

Trillium Gold signs Amended Definitive Agreement for the Eastern Vision properties in Confederation Lake

Retrieved on: 
Wednesday, April 27, 2022

VANCOUVER, British Columbia, April 27, 2022 (GLOBE NEWSWIRE) -- Trillium Gold Mines Inc. (TSXV:TGM, OTCQX:TGLDF, FRA:0702) (Trillium Gold or the Company) is pleased to announce that it has signed an amended Definitive Agreement (the "Definitive Agreement") to acquire the majority of Imagine Lithium Inc.s (formerly Infinite Ore Corp.) Eastern Vision property holdings in the Confederation Lake assemblage within the Birch-Uchi greenstone belt in the Red Lake Mining District of Ontario.

Key Points: 
  • VANCOUVER, British Columbia, April 27, 2022 (GLOBE NEWSWIRE) -- Trillium Gold Mines Inc. (TSXV:TGM, OTCQX:TGLDF, FRA:0702) (Trillium Gold or the Company) is pleased to announce that it has signed an amended Definitive Agreement (the "Definitive Agreement") to acquire the majority of Imagine Lithium Inc.s (formerly Infinite Ore Corp.) Eastern Vision property holdings in the Confederation Lake assemblage within the Birch-Uchi greenstone belt in the Red Lake Mining District of Ontario.
  • The Definitive Agreement as now amended provides for the issuance of 2,800,000 common shares of Trillium Gold and a cash payment of $175,000 to Imagine Lithium.
  • Concurrent with the closing of the Definitive Agreement, Trillium Gold will pay to Pegasus Resources Inc. (Pegasus) $20,000 in cash, as well as 100,000 common shares in the capital of Trillium Gold to earn into certain option agreements that Trillium is assuming as optionee from Imagine Lithium under the Definitive Agreement.
  • The cash consideration represents the remaining option payments under said option agreements, while the equity consideration purchases Pegasus carried interest in the relevant properties such that Trillium Gold will be transferred 100% of those properties upon closing of the Definitive Agreement.

Trillium Gold Closes Uchi and Satterly Gold Purchase Option Agreements Extending its Confederation Belt Land Position in Red Lake, Ontario

Retrieved on: 
Tuesday, April 26, 2022

VANCOUVER, British Columbia, April 26, 2022 (GLOBE NEWSWIRE) -- Trillium Gold Mines Inc. (TSXV:TGM, OTCQX:TGLDF, FRA:0702) (Trillium Gold or the Company) is pleased to announce that on April 25, 2022, it closed the purchase option agreements in respect of the Uchi Gold Project (the Uchi Gold Agreement) and the Satterly Gold Project, (the Satterly Gold Agreement) previously announced on April 5, 2022.

Key Points: 
  • VANCOUVER, British Columbia, April 26, 2022 (GLOBE NEWSWIRE) -- Trillium Gold Mines Inc. (TSXV:TGM, OTCQX:TGLDF, FRA:0702) (Trillium Gold or the Company) is pleased to announce that on April 25, 2022, it closed the purchase option agreements in respect of the Uchi Gold Project (the Uchi Gold Agreement) and the Satterly Gold Project, (the Satterly Gold Agreement) previously announced on April 5, 2022.
  • The Agreements are considered significant steps in strengthening Trillium Golds strategic dominance across the Confederation belt and Birch-Uchi greenstone belts in the Red Lake Mining District.
  • The Uchi Gold Agreement comprises one hundred and eighty-two (182) unpatented mining claims covering 4,189 hectares immediately adjacent to and adjoining the Companys Confederation belt land position.
  • The Satterly Gold Agreement comprises twenty-eight (28) claim cells in five (5) claims covering 565 hectares (called Satterly North).

Kevin Phelps, CPA Appointed Chief Operating Officer of Arev Life Sciences Global Corporation & Warrant Offering

Retrieved on: 
Thursday, April 21, 2022

VANCOUVER, BC , April 21, 2022 (GLOBE NEWSWIRE) -- via InvestorWire -- AREV Life Sciences Global Corp. (CSE: AREV) (OTC: AREVF) (AREV or the Company) AREV Life Sciences Global Corporation announced today the appointment of Kevin Phelps, CPA as Chief Operating Officer.

Key Points: 
  • VANCOUVER, BC , April 21, 2022 (GLOBE NEWSWIRE) -- via InvestorWire -- AREV Life Sciences Global Corp. (CSE: AREV) (OTC: AREVF) (AREV or the Company) AREV Life Sciences Global Corporation announced today the appointment of Kevin Phelps, CPA as Chief Operating Officer.
  • In its current phase of growth and development, AREV Life Sciences Global Corporation appoints Kevin Phelps, CPA and AREV Board Member to the role of Chief Operating Officer.
  • I believe Kevin will bring operational systems and efficiencies to the company as we continue to expand and grow."
  • In conjunction with this appointment, AREV is pleased to announce a retention warrant offering to its senior management of Mike Withrow, CEO, and Kevin Phelps, COO.

Prospect Medical Receives Advanced Provider Partner Award from Wellcare

Retrieved on: 
Wednesday, April 20, 2022

LOS ANGELES, April 20, 2022 /PRNewswire/ -- Prospect Medical Group announced today it has received the Advanced Provider Partner Award from Wellcare, a leading Medicare Advantage plan. The award recognizes Prospect Medical Group for providing excellent quality and service to Wellcare Medicare Advantage members based on the Centers for Medicare & Medicaid Services' (CMS) Plan Year 2022 Star Ratings.

Key Points: 
  • Award Recognizes Excellence in Clinical Quality, Member Experience, and Commitment to Value-Based Care
    LOS ANGELES, April 20, 2022 /PRNewswire/ --Prospect Medical Group announced today it has received the Advanced Provider Partner Award from Wellcare, a leading Medicare Advantage plan.
  • The award recognizes Prospect Medical Group for providing excellent quality and service to Wellcare Medicare Advantage members based on the Centers for Medicare & Medicaid Services' (CMS) Plan Year 2022 Star Ratings.
  • Prospect Medical Group announced today it has received the Advanced Provider Partner Award from Wellcare, a leading Medicare Advantage plan.
  • "We are honored to be recognized as an Advanced Provider Partner by Wellcare," said Jim Brown, CEO of Prospect Medical Systems.

The NatureServe Network Van Tour is Documenting At-Risk Plants and Animals Near You

Retrieved on: 
Wednesday, April 20, 2022

NatureServe is the central coordinating organization for a network of over 60 programs throughout North America.

Key Points: 
  • NatureServe is the central coordinating organization for a network of over 60 programs throughout North America.
  • To better understand local biodiversity conservation across North America, Sean embarked on the NatureServe Network Van Tour : an expedition that highlights how data are used to sustain biodiversity through technology, science, collaboration, and local expertise.
  • Despite many challenges to conserving biodiversity, the Van Tour is documenting examples of how data collected by the NatureServe Network is used to help prioritize which plants, animals, and ecosystems to protect.
  • On the Van Tour, I have witnessed firsthand the passion and dedication with which each program works, said Dr. OBrien.

Trillium Gold Intersects New East-West Structures at Newman Todd

Retrieved on: 
Wednesday, April 20, 2022

VANCOUVER, British Columbia, April 20, 2022 (GLOBE NEWSWIRE) -- Trillium Gold Mines Inc. (TSXV:TGM, OTCQX:TGLDF, FRA:0702) (Trillium Gold or the Company) is pleased to report results from drill holes NT21-195 to -203 and RV21-36A at the Companys 100% owned Newman Todd (NT) Complex.

Key Points: 
  • VANCOUVER, British Columbia, April 20, 2022 (GLOBE NEWSWIRE) -- Trillium Gold Mines Inc. (TSXV:TGM, OTCQX:TGLDF, FRA:0702) (Trillium Gold or the Company) is pleased to report results from drill holes NT21-195 to -203 and RV21-36A at the Companys 100% owned Newman Todd (NT) Complex.
  • Significant intersection highlights from these holes are listed in Table 1 below and can be viewed on sections located on Trillium Golds website at www.trilliumgold.com.
  • Our structural model and interpreted controls on the gold mineralization seem to be holding up well.
  • The E-W fault corridor associated with this gold mineralized zone is a new addition into our model for future targeting.

Iconic Wildflowers in Peril: New Report Highlights Threats to Trillium in North America

Retrieved on: 
Thursday, April 14, 2022

The report, The Conservation Status of Trillium in North America, presents the analysis of 53 plant taxa using two different methodologies.

Key Points: 
  • The report, The Conservation Status of Trillium in North America, presents the analysis of 53 plant taxa using two different methodologies.
  • Authors found that habitat loss, overpopulation of white-tailed deer, and habitat disturbance caused by feral pigs are the primary threats to North American Trillium.
  • Several species of invasive plants that substantially alter native habitats were also identified as major threats to Trillium species.
  • Knapp continued, This report represents work of the most knowledgeable experts and is the most comprehensive and detailed assessment of North America Trillium ever compiled.

Barrow Hanley Global Investors Launches Five Additional Mutual Funds

Retrieved on: 
Wednesday, April 13, 2022

DALLAS, April 13, 2022 /PRNewswire/ -- Perpetual US Services, LLC and Barrow Hanley Global Investors, subsidiaries of Perpetual Limited (ASX:PPT), today announced the conversion of six commingled private funds into five '40 Act registered mutual fund vehicles in order to provide streamlined investment solutions for clients. The newly reorganized funds include:

Key Points: 
  • Converting the private funds into mutual funds provides a modernized solution for clients", said Cory Martin, Chief Executive Officer of Barrow Hanley Global Investors.
  • Distributed by SEI Investment Distribution Co., member FINRA/SIPC; not affiliated with Perpetual Asset Management (Americas) or Barrow Hanley Global Investors.
  • Barrow Hanley stewards the capital of corporate, public, multi-employer pension plans, mutual funds, endowments and foundations, and sovereign wealth funds across North America, Europe, Asia, Australia, and Africa.
  • The division includes the operations of Trillium Asset Management (Trillium), a pioneering US ESG investment specialist, as well as Barrow Hanley Global Investors (Barrow Hanley), a diversified investment management firm that offers value-focused investment strategies spanning global equities, US equities and US fixed income.

IDEAYA Biosciences Appoints Catherine Mackey, Ph.D., to its Board of Directors

Retrieved on: 
Wednesday, April 6, 2022

SOUTH SAN FRANCISCO, Calif., April 6, 2022 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a synthetic lethality focused precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced the appointment of Catherine Mackey, Ph.D., to its Board of Directors. 

Key Points: 
  • SOUTH SAN FRANCISCO, Calif., April 6, 2022 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a synthetic lethality focused precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced the appointment of Catherine Mackey, Ph.D., to its Board of Directors.
  • Dr. Mackey brings over 30 years of life sciences research, development and operational experience to IDEAYA.
  • Dr. Mackey also has considerable relevant experience as a Board Director of several public and private companies.
  • IDEAYA is applying its early research and drug discovery capabilities to synthetic lethality which represents an emerging class of precision medicine targets.